BackPhreesia Overview
Phreesia Inc

Phreesia Target Price

Analysts' average 12-month price target for Phreesia is $13.

Get informed when a big investor buys or sells

+ Follow

Share Price

$10

Average Target Price

$12.5725.7% upside

7 analysts in the last 4 months

High: $16 | Low: $10

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-04D.A. Davidson$1330% upsideOpen
2026-09-04Robert W. BairdJoe Vruwink$1110% upsideOpen
2026-09-03Wells FargoStan Berenshteyn$100% upsideOpen
2026-05-28Piper SandlerJessica Tassan$1220% upsideOpen
2026-05-28D.A. DavidsonClark Wright$1440% upsideOpen
2026-05-28Truist FinancialJailendra Singh$1220% upsideOpen
2026-05-28Canaccord Genuity$1660% upsideOpen
2026-05-20Wells FargoStan Berenshteyn$910% downsideOpen
2026-05-14Barclays$100% upsideOpen
2026-02-04Mizuho SecuritiesSteven Valiquette$22120% upsideOpen
2026-01-23D.A. Davidson$30200% upsideOpen
2026-01-08Wells FargoStan Berenshteyn$30200% upsideOpen
2026-01-08Truist Financial$24140% upsideOpen
2025-12-16Barclays$24140% upsideOpen
2025-12-10Truist Financial$29190% upsideOpen
2025-12-10Mizuho SecuritiesSteven Valiquette$28180% upsideOpen
2025-12-10Robert W. Baird$25150% upsideOpen
2025-12-09Canaccord GenuityRichard Close$33230% upsideOpen
2025-12-08Barclays$26160% upsideOpen
2025-12-02D.A. DavidsonClark Wright$35250% upsideOpen
2025-10-08KeyBanc$32220% upsideOpen
2025-09-08JMP SecuritiesAaron Kimson$34240% upsideOpen
2025-09-05Truist Financial$36260% upsideOpen
2025-09-05Raymond James$33230% upsideOpen
2025-09-05D.A. Davidson$33230% upsideOpen
2025-09-05Canaccord GenuityRichard Close$38280% upsideOpen
2024-12-11Robert W. BairdJoe Vruwink$30200% upsideOpen
2024-11-29D.A. DavidsonGil Luria$32220% upsideOpen
2024-09-06Truist FinancialJailendra Singh$31210% upsideOpen
2024-09-06Robert W. BairdJoe Vruwink$34240% upsideOpen
2024-09-05Piper SandlerSean Wieland$30200% upsideOpen
2024-05-31Canaccord GenuityRichard Close$34240% upsideOpen
2024-05-29Truist FinancialJailendra Singh$35250% upsideOpen
2024-05-24KeyBancScott Schoenhaus$30200% upsideOpen
2024-03-21JMP SecuritiesAaron Kimson$30200% upsideOpen
2024-03-18Robert W. BairdJoe Vruwink$31210% upsideOpen
2024-03-15RBC CapitalSean Dodge$23130% upsideOpen
2023-12-06NeedhamRyan MacDonald$29190% upsideOpen
2023-09-07StephensJeff Garro$37270% upsideOpen
2023-01-04NeedhamRyan MacDonald$40300% upsideOpen
2022-12-09RBC Capital$26160% upsideOpen
2022-10-12D.A. DavidsonRobert Simmons$25150% upsideOpen
2022-03-30Robert W. BairdJoseph Vruwink$51410% upsideOpen
2022-03-30Leerink PartnersStephanie Davis$29190% upsideOpen
2021-09-02Cantor FitzgeraldSteven Halper$70600% upsideOpen
2021-07-12KeyBancDonald Hooker$73630% upsideOpen
2021-06-08Berenberg BankGal Munda$70600% upsideOpen

Phreesia (PHR) FAQ

Phreesia (PHR) currently reports a target price of $13. Use the charts on this page to explore Phreesia's target price history and peer comparisons.

Analysts' average 12-month price target for Phreesia is $13, about 25.7% upside from the current share price of $10.0. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $13, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Phreesia, and consider following PHR for alerts when major investors trade the stock.

Phreesia is classified in the Healthcare sector. On target price, it currently shows $13. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PHR with unrelated industries.